Nutriband Inc.

2.25
-2.15 (-48.86%)
At close: Jan 24, 2025, 3:34 PM
2.25
0.00%
After-hours Jan 24, 2025, 03:34 PM EST
-48.86%
Bid 2.08
Market Cap 105.72M
Revenue (ttm) 5.40M
Net Income (ttm) -18.30M
EPS (ttm) -0.505
PE Ratio (ttm) -4.46
Forward PE n/a
Analyst n/a
Ask 4
Volume 33,656
Avg. Volume (20D) 5,755
Open 4.00
Previous Close 4.40
Day's Range 1.99 - 4.79
52-Week Range 0.19 - 5.25
Beta 0.42

About NTRBW

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The company has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. Nutriband Inc. was incorporated...

Industry Biotechnology
Sector Healthcare
IPO Date Oct 1, 2021
Employees 3
Stock Exchange NASDAQ
Ticker Symbol NTRBW
No News article available yet